On the potential of xanomeline-trospium chloride for schizophrenia and beyond

Eur Neuropsychopharmacol. 2025 Feb 16;94:17-18. doi: 10.1016/j.euroneuro.2025.02.002. Online ahead of print.

NO ABSTRACT

PMID:39961191 | DOI:10.1016/j.euroneuro.2025.02.002